We also observed increased percentages of circulating CXCR3+ Tfh1 cells in patients with APDS/PASLI compared to controls (16), suggesting that PI3K can drive both Tfh cells and Type 1 immunity. This evidence concerns the gene PIK3CD and activated PI3K-delta syndrome.